Source publication: November 9, 2026, at 11:49:29 (UTC+8). This retrospective reflects the reporting and time context of the original BlockBeats article.
Injective’s fifth mainnet anniversary on November 8, 2026, marked a broader change in the project’s ambitions: a protocol originally designed to prevent front-running had become a blockchain pursuing regulated securities infrastructure, institutional asset issuance and exchange-listed investment products.
In its retrospective, BlockBeats traced that shift through several jurisdictions, including the United States, Canada, Thailand and South Korea. The developments involved distinct legal and commercial steps—not a single regulatory approval of the network or everything traded on it.
United States: registration and ETF access
A central development was the registration of Injective Institutional Services, an Injective subsidiary, as a transfer agent with the U.S. Securities and Exchange Commission. According to the report, the application was submitted on July 16, 2026, and became effective on August 19.
Transfer agents maintain securities ownership records and administer functions associated with registered shareholders. The article reported that the registration would allow ownership records for tokenized securities issued on Injective to be maintained directly onchain. Injective described itself as the first Layer 1 blockchain with its own transfer agent; that distinction was the project’s claim.
The registration followed a sustained policy effort. Injective Labs submitted written comments to the SEC’s Crypto Task Force in July and October 2025, including a submission arguing that DeFi lending was not securities trading. A January 13, 2026, meeting with the task force included transfer agents on its agenda. In May, the project established the Injective Policy Institute in Washington, led by policy executive John Medel, previously of Coinbase and Goldman Sachs.
These submissions and meetings were advocacy and engagement, rather than regulatory adoption of Injective’s positions.
INJ investment products
BlockBeats reported that SEC generic listing standards adopted in September 2025 included a route for eligible crypto assets with at least six months of trading in a CFTC-regulated futures market. Bitnomial launched U.S. CFTC-regulated INJ futures on April 15, 2026, putting the six-month milestone on October 15.
Canary Capital, 21Shares and REX-Osprey had submitted INJ ETF applications in 2025. The report identified Canary’s staking ETF, trading under INJC, as having begun Nasdaq trading on November 5, 2026, followed by a bell-ringing celebration on November 6. The article’s opening scene describes the November 6 ceremony as the listing moment, but its later account specifies November 5 as the first trading day.
According to the November 4 final prospectus described in the report:
- At least 90% of the fund’s INJ was intended to be staked.
- BitGo would provide token custody.
- The annual management fee was 1.1%.
- Staking providers, the custodian and the sponsor would collectively receive 30% of staking rewards, with the remaining 70% reflected in the fund’s net asset value.
Europe and Thailand: different regulatory routes
At its July 16 Washington summit, Injective announced completion of notification for its European MiCA white paper. That was a white-paper notification milestone, not a blanket approval of all Injective-based products.
In Thailand, the report said licensed digital-asset fund manager Merkle Capital launched M-INJ on June 4, 2026, under Thai SEC supervision. BlockBeats described it as Asia’s first regulated fund designed around INJ.
The fund was available to retail and institutional investors, with a minimum investment of 500,000 baht. It held INJ and USDC, could increase its USDC allocation in weaker market conditions, and maintained an annual average allocation of at least 80% to digital assets. Subscriptions and redemptions were available on business days.
Tokenization: Canadian mortgage records and Korean trade receivables
Injective’s January 2024 Volan upgrade introduced a native real-world-asset module supporting permissioned assets. Institutions could embed eligibility, whitelisting and jurisdictional transfer restrictions into asset rules.
One application came from Toronto mortgage-technology company Pineapple, which the source said had recently rebranded as Pentiv. In December 2025, it began recording mortgage files onchain, with more than 500 data points per record, while leaving the underlying loan contracts and servicing arrangements unchanged.
By September 2026, the report said those records represented more than $1 billion across 2,079 mortgages, against a stated target of 29,000 mortgages worth $10 billion. Recording mortgage information onchain should not be confused with transferring or rewriting the underlying loan contracts.
In South Korea, POSCO International and LG CNS used Injective for a July 2026 proof of concept involving tokenized cross-border trade receivables. AI agents reviewed letters of credit and trade documents for errors during initial checks. POSCO planned to determine a pilot framework in the second half of the year; the report did not describe a completed full-scale rollout.
On October 20, Injective also signed a memorandum of understanding with digital-asset custodian BDACS. Under the proposed arrangement, BDACS-issued KRW1 would serve as a won-denominated settlement asset for real-world and tokenized assets on Injective. The memorandum was a cooperation step, not evidence of universal adoption by Korean institutions.
From exchange protocol to financial infrastructure
Founded by Eric Chen and Albert Chon, Injective entered Binance Labs’ first incubation cohort in 2018. Its original white paper proposed an Ethereum-based decentralized exchange protocol addressing front-running. Mainnet followed on November 8, 2021.
An October 2026 replacement white paper presented a broader identity: a Layer 1 built for institutional finance and tokenization, connecting asset issuance, trading, settlement and automated agents.
The institutional shift did not eliminate the importance of legal intermediaries. Instead, Injective’s approach increasingly combined blockchain execution with regulated functions, permissioned asset controls and conventional investment vehicles. The transfer-agent registration, ETF listing, MiCA notification and regional partnerships each addressed different parts of that strategy—and retained different legal scopes.